
Mayinglong Pharmaceutical Group Co., LTD.
SSE:600993.SS
29.4 (CNY) • At close June 6, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Omzet
| 3,728.024 | 3,136.746 | 3,532.379 | 3,385.059 | 2,791.592 | 2,705.396 | 2,197.507 | 1,750.592 | 2,102.807 | 1,783.682 | 1,620.801 | 1,602.282 | 1,542.034 | 1,415.545 | 1,178.495 | 1,021.983 | 809.631 | 548.634 | 535.599 | 411.791 | 370.99 | 325.645 | 248.117 | 204.906 |
Kosten van de omzet
| 1,992.487 | 1,829.482 | 2,034.2 | 2,017.572 | 1,662.506 | 1,595.507 | 1,206.472 | 874.252 | 1,339.436 | 1,079.573 | 943.305 | 916.523 | 900.828 | 857.55 | 733.987 | 634.979 | 494.727 | 312.282 | 277.58 | 173.111 | 159.902 | 132.338 | 84.985 | 68.478 |
Brutowinst
| 1,735.537 | 1,307.265 | 1,498.179 | 1,367.487 | 1,129.086 | 1,109.889 | 991.035 | 876.341 | 763.371 | 704.109 | 677.496 | 685.76 | 641.207 | 557.995 | 444.508 | 387.005 | 314.904 | 236.352 | 258.019 | 238.68 | 211.088 | 193.306 | 163.132 | 136.427 |
Brutowinstmarge
| 0.466 | 0.417 | 0.424 | 0.404 | 0.404 | 0.41 | 0.451 | 0.501 | 0.363 | 0.395 | 0.418 | 0.428 | 0.416 | 0.394 | 0.377 | 0.379 | 0.389 | 0.431 | 0.482 | 0.58 | 0.569 | 0.594 | 0.657 | 0.666 |
Onderzoek- en ontwikkelingskosten
| 59.529 | 69.014 | 77.891 | 66.733 | 55.663 | 55.292 | 40.889 | 37.732 | 31.361 | 29.178 | 26.069 | 30.519 | 28.686 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Algemene en administratieve kosten
| 33.119 | 35.379 | 35.73 | 36.469 | 42.289 | 39.057 | 40.412 | 42.041 | 42.161 | 32.393 | 32.481 | 114.983 | 102.376 | 81.905 | 69.244 | 61.817 | 54.622 | 59.359 | 51.76 | 48.974 | 41.502 | 42.087 | 34.214 | 33.589 |
Verkoop- en marketingkosten
| 696.464 | 479.634 | 780.743 | 717.274 | 594.78 | 574.459 | 529.629 | 465.034 | 390.412 | 354.72 | 356.472 | 367.161 | 363.072 | 285.566 | 241.905 | 200.588 | 148.779 | 118.011 | 116.65 | 112.477 | 101.736 | 100.01 | 87.667 | 67.671 |
Verkoop-, algemene en administratieve kosten
| 729.583 | 515.013 | 816.473 | 753.743 | 637.07 | 613.517 | 570.041 | 507.075 | 432.573 | 387.113 | 388.954 | 482.144 | 465.447 | 367.471 | 311.148 | 262.406 | 203.401 | 177.37 | 168.41 | 161.45 | 143.238 | 142.097 | 121.881 | 101.261 |
Overige kosten
| 272.441 | -127.607 | 77.074 | 72.789 | 52.105 | 50.522 | -1.498 | -1.1 | 18.988 | 10.537 | 9.967 | 12.418 | 12.3 | 6.264 | 8.691 | 6.015 | 3.751 | -1.085 | 2.219 | 2.882 | -0.673 | 1.912 | 2.353 | 4.255 |
Bedrijfskosten
| 1,068.715 | 770.636 | 971.438 | 893.265 | 744.837 | 719.331 | 672.871 | 599.65 | 530.144 | 495.411 | 489.262 | 498.125 | 481.633 | 382.023 | 321.924 | 271.616 | 211.47 | 183.109 | 174.73 | 166.988 | 148.297 | 146.606 | 125.619 | 104.568 |
Bedrijfsresultaat
| 666.822 | 536.628 | 555.538 | 550.305 | 500.47 | 424.599 | 193.232 | 365.939 | 261.337 | 237.372 | 215.249 | 202.865 | 187.375 | 153.914 | 136.219 | 214.609 | 85.966 | 186.035 | 92.293 | 75.157 | 64.466 | 46.405 | 36.063 | 31.514 |
Bedrijfsresultaat ratio
| 0.179 | 0.171 | 0.157 | 0.163 | 0.179 | 0.157 | 0.088 | 0.209 | 0.124 | 0.133 | 0.133 | 0.127 | 0.122 | 0.109 | 0.116 | 0.21 | 0.106 | 0.339 | 0.172 | 0.183 | 0.174 | 0.143 | 0.145 | 0.154 |
Totaal overige inkomsten en kosten netto
| -9.268 | -11.925 | 3.597 | -2.146 | -2.779 | -2.189 | -1.498 | -1.1 | 1.682 | 10.385 | 7.091 | 12.214 | 12.007 | -12.684 | 8.021 | 105.152 | -13.985 | 131.523 | 1.445 | 0.774 | -1.377 | 1.34 | 2.333 | 3.178 |
Inkomen voor belasting
| 657.554 | 524.703 | 559.135 | 548.159 | 497.691 | 422.411 | 191.734 | 364.839 | 279.687 | 247.757 | 222.34 | 215.078 | 199.382 | 159.826 | 144.24 | 220.541 | 89.449 | 184.766 | 92.503 | 75.93 | 63.089 | 47.745 | 38.395 | 34.692 |
Inkomen voor belasting ratio
| 0.176 | 0.167 | 0.158 | 0.162 | 0.178 | 0.156 | 0.087 | 0.208 | 0.133 | 0.139 | 0.137 | 0.134 | 0.129 | 0.113 | 0.122 | 0.216 | 0.11 | 0.337 | 0.173 | 0.184 | 0.17 | 0.147 | 0.155 | 0.169 |
Belastingkosten
| 109.255 | 72.864 | 78.826 | 74.109 | 67.048 | 69.016 | 27.176 | 55.993 | 46.689 | 36.813 | 30.07 | 37.403 | 31.892 | 24.796 | 24.475 | 31.348 | 17.452 | 33.764 | 18.051 | 14.581 | 11.743 | 8.136 | 4.337 | 5.73 |
Nettowinst
| 528.094 | 443.251 | 478.572 | 464.592 | 419.058 | 359.967 | 176.208 | 320.051 | 250.244 | 223.256 | 201.478 | 186.324 | 173.798 | 137.726 | 122.538 | 180.081 | 80.429 | 133.404 | 71.871 | 60.06 | 52.637 | 39.781 | 32.944 | 27.543 |
Nettowinstmarge
| 0.142 | 0.141 | 0.135 | 0.137 | 0.15 | 0.133 | 0.08 | 0.183 | 0.119 | 0.125 | 0.124 | 0.116 | 0.113 | 0.097 | 0.104 | 0.176 | 0.099 | 0.243 | 0.134 | 0.146 | 0.142 | 0.122 | 0.133 | 0.134 |
WPA (Winst Per Aandeel)
| 1.23 | 1.03 | 1.11 | 1.08 | 0.97 | 0.84 | 0.41 | 0.74 | 0.58 | 0.52 | 0.47 | 0.43 | 0.4 | 0.32 | 0.28 | 0.42 | 0.19 | 0.31 | 0.17 | 0.12 | 0.1 | 0.12 | 0.075 | 0.063 |
Verwaterde WPA
| 1.23 | 1.03 | 1.11 | 1.08 | 0.97 | 0.84 | 0.41 | 0.74 | 0.58 | 0.52 | 0.47 | 0.43 | 0.4 | 0.32 | 0.28 | 0.42 | 0.19 | 0.31 | 0.17 | 0.12 | 0.1 | 0.12 | 0.075 | 0.063 |
EBITDA
| 745.931 | 633.251 | 654.66 | 619.507 | 552.173 | 478.189 | 232.2 | 403.508 | 331.938 | 287.892 | 268.146 | 254.607 | 235.148 | 186.439 | 169.857 | 245.485 | 110.866 | 210.576 | 113.551 | 91.064 | 76.25 | 62.149 | 43.202 | 39.569 |
EBITDA ratio
| 0.2 | 0.202 | 0.185 | 0.183 | 0.198 | 0.177 | 0.106 | 0.23 | 0.158 | 0.161 | 0.165 | 0.159 | 0.152 | 0.132 | 0.144 | 0.24 | 0.137 | 0.384 | 0.212 | 0.221 | 0.206 | 0.191 | 0.174 | 0.193 |